180 related articles for article (PubMed ID: 6201588)
1. Selection of strongly immunogenic "tum-" variants from tumors at high frequency using 5-azacytidine.
Frost P; Liteplo RG; Donaghue TP; Kerbel RS
J Exp Med; 1984 May; 159(5):1491-501. PubMed ID: 6201588
[TBL] [Abstract][Full Text] [Related]
2. Possible epigenetic mechanisms of tumor progression: induction of high-frequency heritable but phenotypically unstable changes in the tumorigenic and metastatic properties of tumor cell populations by 5-azacytidine treatment.
Kerbel RS; Frost P; Liteplo R; Carlow DA; Elliott BE
J Cell Physiol Suppl; 1984; 3():87-97. PubMed ID: 6205005
[TBL] [Abstract][Full Text] [Related]
3. Increased frequency of immunogenic variants obtained by repeated mutagen treatment of mouse mastocytoma P815.
Marchand M; Caspar P; Boon T
Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1529-37. PubMed ID: 6196202
[TBL] [Abstract][Full Text] [Related]
4. Lack of correlation between DNA-methylating activity and appearance of the immunogenic phenotype in clones of a murine lymphoma treated with mutagens.
Fuschiotti P; Fioretti MC; Romani L; Puccetti P
Cancer Immunol Immunother; 1989; 29(2):139-43. PubMed ID: 2470506
[TBL] [Abstract][Full Text] [Related]
5. In situ augmentation of class I major histocompatibility antigen expression on immunogenic variants of a spontaneous murine mammary carcinoma.
Elliott BE; Carlow DA; Ivimey L; Arnold M; Hampton N; Bosman P
Cancer Res; 1987 Sep; 47(18):4915-23. PubMed ID: 2441856
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of class I major histocompatibility complex gene (Dk) products on immunogenic variants of a spontaneous murine carcinoma.
Carlow DA; Kerbel RS; Feltis JT; Elliott BE
J Natl Cancer Inst; 1985 Aug; 75(2):291-301. PubMed ID: 2410653
[TBL] [Abstract][Full Text] [Related]
7. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones.
Maryanski JL; Boon T
Eur J Immunol; 1982 May; 12(5):406-12. PubMed ID: 6178608
[TBL] [Abstract][Full Text] [Related]
8. Immunogenic (tum-) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a tum- antigen with a cytolytic T cell stimulation assay.
Wölfel T; Van Pel A; De Plaen E; Lurquin C; Maryanski JL; Boon T
Immunogenetics; 1987; 26(3):178-87. PubMed ID: 3114137
[TBL] [Abstract][Full Text] [Related]
9. Effects of mutagens on the immunogenicity of tumor cells: comparison of cell surface changes induced by 5-azacytidine and N-methyl-N'-nitro-N-nitrosoguanidine.
Altevogt P
Cancer Res; 1986 Jun; 46(6):2912-6. PubMed ID: 2421887
[TBL] [Abstract][Full Text] [Related]
10. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. VII. Dominant expression of variant antigens in somatic cell hybrids.
Maryanski JL; Szpirer J; Szpirer C; Boon T
Somatic Cell Genet; 1983 May; 9(3):345-57. PubMed ID: 6407125
[TBL] [Abstract][Full Text] [Related]
11. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. V. H-2 associativity of variant-specific antigens.
Van Snick J; Maryanski J; Van Pel A; Parmiani G; Boon T
Eur J Immunol; 1982 Nov; 12(11):905-8. PubMed ID: 6818041
[TBL] [Abstract][Full Text] [Related]
12. Effects of mutagens on the immunogenicity of murine tumor cells: immunological and biochemical evidence for altered cell surface antigens.
Altevogt P; von Hoegen P; Leidig S; Schirrmacher V
Cancer Res; 1985 Sep; 45(9):4270-7. PubMed ID: 4028013
[TBL] [Abstract][Full Text] [Related]
13. Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation.
De Plaen E; Lurquin C; Van Pel A; Mariamé B; Szikora JP; Wölfel T; Sibille C; Chomez P; Boon T
Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2274-8. PubMed ID: 3127830
[TBL] [Abstract][Full Text] [Related]
14. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice.
Uyttenhove C; Van Snick J; Boon T
J Exp Med; 1980 Nov; 152(5):1175-83. PubMed ID: 6776226
[TBL] [Abstract][Full Text] [Related]
15. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response.
Maryanski JL; Van Snick J; Cerottini JC; Boon T
Eur J Immunol; 1982 May; 12(5):401-6. PubMed ID: 6178607
[TBL] [Abstract][Full Text] [Related]
16. Tumour cell variants with increased immunogenicity obtained by mutagen treatment.
Boon T; Maryanski J
Cancer Surv; 1985; 4(1):135-48. PubMed ID: 3879855
[TBL] [Abstract][Full Text] [Related]
17. Mutagen treatment as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant murine tumors.
Frost P; Kerbel RS; Bauer E; Tartamella-Biondo R; Cefalu W
Cancer Res; 1983 Jan; 43(1):125-32. PubMed ID: 6401163
[No Abstract] [Full Text] [Related]
18. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. VI. Occasional escape from host rejection due to antigen-loss secondary variants.
Maryanski JL; Marchand M; Uyttenhove C; Boon T
Int J Cancer; 1983 Jan; 31(1):119-23. PubMed ID: 6187698
[TBL] [Abstract][Full Text] [Related]
19. Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N'-nitronitrosoguanidine.
Gorelik E; Peppoloni S; Overton R; Herberman RB
Cancer Res; 1985 Nov; 45(11 Pt 1):5341-7. PubMed ID: 2413992
[TBL] [Abstract][Full Text] [Related]
20. Identification of genes encoding T cell defined tum- antigens.
Van Pel A; De Plaen E; Lurquin C; Van den Eynde B; Lethé B; Hainaut P; Lemoine C; Boon T
Princess Takamatsu Symp; 1988; 19():255-63. PubMed ID: 3151988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
